FarmaJournal

Make a submission

About the Journal

Focus and Scope

FarmJournal reflects the experimental work of undergraduate or master's degree from the Faculty of Pharmacy, as well as summaries of the various conferences and activities carried out in the faculty (Farmaforum Lectures Academy of Pharmacy of Castilla y Leon, research seminars).

Peer Review Process

All contributions presented will be analyzed by external raters according to strict criteria of scientific quality. It is the job of the Editorial Board to emit the final decision based on the reports of the reviewers.

  • Acknowledgement of reception: Once the contribution has arrived the Journal will acknowledge its arrival and it will be reviewed, the final decision regarding publication corresponding to the Editorial Board.
  • Peer review system: Each contribution will be reviewed by at least two members of the editorial Board, and possibly a third one in the case of discrepancy and also by an expert in methodology.
  • Suggestions about reviewers: Authors will be able to suggest the name of a possible reviewer they consider to be ideal for reviewing their contribution. They must indicate the reviewer’s e-mail. They will also be able to indicate anybody they do not wish to become involved in the review process. In any case, there will always be another two reviewers, the final decision corresponding to the Editorial Board.
  • Communications to the author/s: Notification of the acceptance, or not, of original articles will be communicated to the main author within a maximum of 120 days as from acknowledgement of the reception of the article.
  • Double anonymity in the review process: the originals will not be returned and no correspondence about the contribution with the authors will be initiated. In the review process, double anonymity will be the norm.
  • External reviewers: When necessary, external evaluators working outside the sphere of the Journal will be asked to review the contribution.

No Charges for Levied Processing Contributions or for Publication in Open Access Format (APC)

The Journal does not levy charges for processing of articles, nor for editing them or publishing them in open access format [article processing charges (APCs)]

Sections of the Journal

The Journal FarmaJournal is divided into several sections:

  1. Foreword
  2. Index
  3. Research Reports
  4. Analytical Summary
  5. Conferences of the Castilla and Leon Pharmacy Academy
  6. Faculty of Pharmacy to University of Salamanca Conferences
  7. Papers Farmaforum

Commitment to Research Submitted by New Authors and Authors from Developing Countries

The Journal FarmaJournal supports the research carried out by authors or research teams from developing countries, especially from Latin-America, whose texts are presented in scientific language, Spanish or preferably in English.

Permission to Self-Archive and Digital Preservation

Authors are authorized to publish on the internet (for example, in institutional repositories or personal web sites) after publication (in no case prior to the review, layout or even in the phase of proof-reading); in the event of embargo, immediately after this has expired. It is also permitted in cases in which the costs of APCs (article processing charges) have been paid to the Editorial Board. These measures are designed to foster the reading and citation of contributions and to achieve greater and faster dissemination of the work published (see The Effect of Open Access)

The Journal can be accessed from the two main repositories of the University of Salamanca:

This Journal uses the LOCKSS system to create an archive distributed among the participating libraries, allowing them to create permanent archives of the Journal with a view to preservation and restoration.

Open Access Policy

This Journal offers open access to its content, based on the principle of offer the public free access to research results and helping greater global exchange of knowledge.

Dissemination in Databases

The Journal is committed to the provision of XML metadata or in other specific formats, immediately after publication in «eUSAL Revistas» and before three months have elapsed in order to foster diffusion in databases (Proquest, Ebsco, Elsevier, DOAJ, CrossRef/DOI).

Download Statistics

The authors whose articles have been published since October 2020, can see the download statistics in the article file. Those prior to that date will have to be requested from the Editorial Office.

Golden Roads to Open Access

Salamanca University Press, will implement Golden Roads to Open Access as of 2011, and it will be possible to access complete texts in PDF format of the Journal ADCAIJ meeting the provisions of Enactment 14/2011, 1st June, concerning Science, Technology and Innovation.

Thematics

Contributions must be original, unpublished and should not have been submitted to «Pharmacology». 

 

Materias IBIC:

  • MMG Farmacología
  • MGT Toxicología médica
  • MMZ Tratamiento y terapéutica
  • MX  Medicina complementaria
  • VXH Terapias complementarias, curación y salud

BIC Standard Subject:

  • MMG Pharmacology
  • MMGT Medical toxicology
  • MMZ Therapy & therapeutics
  • MX Complementary Medicine
  • VXH Complementary therapies, healing & health

BISAC Subject Codes:

  • MED071000        MEDICAL / Pharmacology
  • MED096000        MEDICAL / Toxicology
  • MED003000        MEDICAL / Allied Health Services / General
  • MED000000        MEDICAL / General
  • OCC011000        BODY, MIND & SPIRIT / Healing / General

Language, Identification of Text Authorship

Language

Contributions will be published in Spanish or English and, exceptionally, in other languages.

Text Identification

The texts must always be identified with the following data:

  1. Title, Abstract and Key Words (+intro) in Spanish.
  2. Title, Abstract and Key Words (+intro) in English.
  3. Title, Abstract and Key Words (+intro) in the source language of the contribution.

Authority Control 

The authors must specify their affiliation:

  1. Name: Lower case
  2. Second name: Lower case
  3. Surname(s): Lower case
  4. E-mail address: institutional but neither G-mail (generic) nor similar, etc.
  5. ORCID: previously registered in ORCID
  6. The institution: University or Research Institute
  7. Country
  8. Full postal address.

 

Ethics and Accountability of the Journal

Upon submitting their originals to the Journal, authors must commit to accepting the usual procedures in the scientific community; only originals that have not been published previously and that are not undergoing review by other journals can be accepted. Thus, the originals sent to the Journal will cannot be sent to other journals while they are still undergoing review by our Journal.

Authors must respect international norms concerning authors’ rights to the text, graphics and other materials included in their contributions submitted to the Journal for publication. In turn, the editors, the editorial board and the reviewers of the journal will ensure the integrity of the research is maintained, which in the first instance is the responsibility of the authors, reminding them of the use of software «Turnitin Ephorus» https://moodle2.usal.es/mod/page/view.php?id=260582. Accordingly, authors are requested not to engage in plagiarism or self-plagiarism.

Accountability of the Journal

  • The Editorial Board will not be responsible for the ideas and opinions expressed by authors in articles published in the Journal.
  • Once an article has been accepted for publication, it is assumed that all the authors have agreed to its diffusion, the right to reproduction in any format belonging to FarmaJournal.
  • Once the article has been published, the author will receive a separatum in PDF format from the Journal in which it has been published.

Committee on Publication Ethics (COPE)

This Journal adheres to the principle of transparency and good practices set by the Committee on Publication Ethics (COPE).

Concerning © and CC BY-NC-ND rights

Authors publishing in FarmaJournal must agree to accept the following conditions:

The authors conserve the copyright © and cede the publication rights to Salamanca University Press, under the license Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International (CC BY-NC-ND 4.0), which allows third parties the possibility of distributing and exhibiting the article as long as they cite the authorship, it publication in the FarmaJournal, the specific issue, and the pages on which the information appears. Derived works for commercial purposes not authorized by the editorial Board are not permitted.

Authors may engage in other independent and additional contractual agreements for the non-exclusive diffusion of the version of their article published in FarmaJournal as long as:

  • It is clearly indicated that the work was published in the Journal FarmaJournal, together with the specific issues and the pages on which the information quoted appears.

The information of the Journal will be transmitted to Sherpa / Romeo, Dulcinea, etc.

 

DORA

Latin America Today supports the "Declaration of San Francisco on evaluation of research" - DORA.

 

Information on the specific contribution of each of the authors to the published articles

The order of signatures/affiliation in the article should reflect the effort and contribution.

 

Registration funder of articles published

The funding agency(ies) external to University must be indicated, indicating the reference(s) of the project(s) in the framework of which the research that has given rise to the publication of the article has been carried out. This information should be referenced by the authors in the acknowledgements in the article. The corresponding author in charge of submitting the article to «eUSAL Revistas» must include this metadata at the time of the submit in the corresponding section.

Good editorial practices in gender equality

Good practice in gender equality requires that:

  • Articles should include, as far as possible, the use of inclusive language;
  • Authors should include full names (not just first initials), at least in the metadata;
  • Being aware of the protection of personal data, the journal would appreciate information on the sex of the signatory(s) in the metadata, in order to enable the identification of possible gender differences;

 

Interoperability protocols

The OAI-PMH protocol is used with the route <https://revistas.usal.es/cinco/index.php/2445-1355/oai/>